{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:40:56Z","timestamp":1781545256895,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.det.2021.12.004","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T17:21:44Z","timestamp":1646414504000},"page":"167-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hormonal Treatment of Acne and Hidradenitis Suppurativa in Adolescent Patients"],"prefix":"10.1016","volume":"40","author":[{"given":"Ryan M.","family":"Svoboda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanjiba","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Zaenglein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2021.12.004_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4161\/derm.1.2.8354","article-title":"Hormones and the pilosebaceous unit","volume":"1","author":"Chen","year":"2009","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.det.2021.12.004_bib2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1747.2002.00613.x","article-title":"Cutaneous androgen metabolism: basic research and clinical perspectives","volume":"119","author":"Chen","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1523-1747.2003.12244.x","article-title":"Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1)","volume":"120","author":"Thiboutot","year":"2003","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib4","first-page":"218","article-title":"Intracrinology and the skin","volume":"54","author":"Labrie","year":"2000","journal-title":"Horm Res"},{"key":"10.1016\/j.det.2021.12.004_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clindermatol.2016.10.004","article-title":"Sex hormones and acne","volume":"35","author":"Ju","year":"2017","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00403-009-1019-6","article-title":"Effect of dihydrotestosterone on the upregulation of inflammatory cytokines in cultured sebocytes","volume":"302","author":"Lee","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2021.12.004_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.det.2021.12.004_bib8","first-page":"104","article-title":"Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction","volume":"3","author":"Panzer","year":"2006","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.det.2021.12.004_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clindermatol.2016.10.009","article-title":"Hormonal therapies for acne","volume":"35","author":"Barros","year":"2017","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib10","first-page":"1839","article-title":"Using progestins in clinical practice","volume":"62","author":"Apgar","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.det.2021.12.004_bib11","doi-asserted-by":"crossref","first-page":"116s","DOI":"10.1016\/S0002-9343(99)80069-2","article-title":"Androgenic effects of oral contraceptives: implications for patient compliance","volume":"98","author":"Jones","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.det.2021.12.004_bib12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib13","first-page":"83","article-title":"Combined oral contraceptives for the treatment of acne: a practical guide","volume":"90","author":"Arrington","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.det.2021.12.004_bib14","first-page":"670","article-title":"Hormonal contraceptives and acne: a retrospective analysis of 2147 patients","volume":"15","author":"David Lortscher","year":"2016","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0010-7824(90)90039-X","article-title":"Progestational and androgenic receptor binding affinities and in\u00a0vivo activities of norgestimate and other progestins","volume":"41","author":"Phillips","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.det.2021.12.004_bib16","doi-asserted-by":"crossref","DOI":"10.5070\/D3245040035","article-title":"Progestins and acne vulgaris: a review","volume":"24","author":"Bosanac","year":"2018","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2021.12.004_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/TCRM.S6864","article-title":"Use of ethinylestradiol\/drospirenone combination in patients with the polycystic ovary syndrome","volume":"4","author":"Mathur","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.det.2021.12.004_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2017.07.063","article-title":"Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy","volume":"491","author":"Louw-du Toit","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.det.2021.12.004_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub5","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.det.2021.12.004_bib20","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.det.2021.12.004_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2014.03.051","article-title":"Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris","volume":"71","author":"Koo","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa","volume":"14","author":"von der Werth","year":"2000","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2021.12.004_bib23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/bjs.1800751011","article-title":"Endocrine basis for the clinical presentation of hidradenitis suppurativa","volume":"75","author":"Harrison","year":"1988","journal-title":"Br J Surg"},{"key":"10.1016\/j.det.2021.12.004_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib25","doi-asserted-by":"crossref","DOI":"10.5070\/D32310036990","article-title":"Hormonal therapies for hidradenitis suppurativa: review","volume":"23","author":"Clark","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2021.12.004_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American Clinical Management Guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib27","first-page":"183","article-title":"Most British women use reliable contraceptive methods, but many fear health risks from use","volume":"26","author":"Turner","year":"1994","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.det.2021.12.004_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.contraception.2003.07.003","article-title":"What women believe about oral contraceptives and the effect of counseling","volume":"69","author":"Gaudet","year":"2004","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.det.2021.12.004_bib29","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.det.2021.12.004_bib30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/1471-0528.15027","article-title":"Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review","volume":"125","author":"Simmons","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.det.2021.12.004_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajog.2017.07.003","article-title":"Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review","volume":"218","author":"Simmons","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.det.2021.12.004_bib32","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000003072","article-title":"ACOG Practice Bulletin No. 206: use of hormonal contraception in women with coexisting medical conditions","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.det.2021.12.004_bib33","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.det.2021.12.004_bib34","article-title":"Time-dependent effects of oral contraceptive use on breast, ovarian and endometrial cancers","author":"Karlsson","year":"2020","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.det.2021.12.004_bib35","article-title":"Types of progestogens in combined oral contraception: effectiveness and side-effects","author":"Lawrie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.det.2021.12.004_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpag.2020.01.003","article-title":"Bones and birth control in adolescent girls","volume":"33","author":"Golden","year":"2020","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"issue":"Suppl 3","key":"10.1016\/j.det.2021.12.004_bib37","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1542\/peds.2013-0490B","article-title":"Evidence-based recommendations for the diagnosis and treatment of pediatric acne","volume":"131","author":"Eichenfield","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.det.2021.12.004_bib38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","article-title":"The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.det.2021.12.004_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.contraception.2008.05.002","article-title":"Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study","volume":"78","author":"Pikkarainen","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.det.2021.12.004_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12902-015-0012-7","article-title":"Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period","volume":"15","author":"Biason","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.det.2021.12.004_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/0897190012442066","article-title":"The effect of hormonal oral contraception on acquisition of peak bone mineral density of adolescents and young women","volume":"25","author":"Ziglar","year":"2012","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.det.2021.12.004_bib42","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpag.2016.05.012","article-title":"Effect of extended 30 \u03bcg ethinyl estradiol with continuous low-dose ethinyl estradiol and cyclic 20 \u03bcg ethinyl estradiol oral contraception on adolescent bone density: a randomized trial","volume":"29","author":"Gersten","year":"2016","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.det.2021.12.004_bib43","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.det.2021.12.004_bib44","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.det.2021.12.004_bib45","article-title":"Combined oral contraceptives: venous thrombosis","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.det.2021.12.004_bib46","first-page":"59","article-title":"Risk of venous thromboembolism in women taking the combined oral contraceptive: a systematic review and meta-analysis","volume":"45","author":"Bateson","year":"2016","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.det.2021.12.004_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.det.2015.11.005","article-title":"Use of oral contraceptives for management of acne vulgaris: practical considerations in real world practice","volume":"34","author":"Harper","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2021.12.004_bib48","series-title":"Cardiovascular disease and steroid contraception: report of a WHO Scientific Group","first-page":"1","year":"1998"},{"key":"10.1016\/j.det.2021.12.004_bib49","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"2015","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.det.2021.12.004_bib50","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00404-018-4723-7","article-title":"Association between oral contraceptives and risk of hemorrhagic stroke: a meta-analysis of observational studies","volume":"297","author":"Xu","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.det.2021.12.004_bib51","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clpt.2004.01.003","article-title":"The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone","volume":"75","author":"Hendrix","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.det.2021.12.004_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2015.05.127","article-title":"Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone","volume":"200","author":"Lainscak","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.det.2021.12.004_bib53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-46-2-338","article-title":"Interaction of digitalis and spironolactone with human sex steroid receptors","volume":"46","author":"Rifka","year":"1978","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.det.2021.12.004_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/1523-1747.ep12472325","article-title":"Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in\u00a0vitro","volume":"100","author":"Akamatsu","year":"1993","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-4731(85)90236-5","article-title":"The effect of spironolactone on genital skin 5 alpha-reductase activity","volume":"23","author":"Serafini","year":"1985","journal-title":"J\u00a0Steroid Biochem"},{"key":"10.1016\/j.det.2021.12.004_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/pde.14391","article-title":"Use of spironolactone to treat acne in adolescent females","volume":"38","author":"Roberts","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2020.12.071","article-title":"Long-term use of spironolactone for acne in women: a case series of 403 patients","author":"Garg","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","article-title":"Oral spironolactone: an effective treatment for acne vulgaris in women","volume":"115","author":"Muhlemann","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A\u00a0case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/120347540200600604","article-title":"Long-term safety of spironolactone in acne: results of an 8-year followup study","volume":"6","author":"Shaw","year":"2002","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.det.2021.12.004_bib61","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/EJE-14-0444","article-title":"Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy","volume":"172","author":"Riester","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.det.2021.12.004_bib62","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","article-title":"Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne","volume":"151","author":"Plovanich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","article-title":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone","volume":"58","author":"Krunic","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.12.004_bib64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-020-00557-5","article-title":"Hormonal contraceptives and dermatology","volume":"22","author":"Williams","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijwd.2020.09.002","article-title":"Characterizing perimenstrual flares of hidradenitis suppurativa","volume":"6","author":"Collier","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib66","doi-asserted-by":"crossref","DOI":"10.1177\/1060028021992053","article-title":"Clascoterone: a novel topical androgen receptor inhibitor for the treatment of acne","author":"Kalabalik-Hoganson","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.det.2021.12.004_bib67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2021.12.004_bib68","unstructured":"Contraceptives PO, Role ANP: continuing education for pharmacists & pharmacy technicians."},{"key":"10.1016\/j.det.2021.12.004_bib69","series-title":"Medical eligibility criteria for contraceptive use","year":"2010"},{"key":"10.1016\/j.det.2021.12.004_bib70","series-title":"Slynd pacakge insert","year":"2019"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863521000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863521000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:45:44Z","timestamp":1760006744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863521000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0733863521000942"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2021.12.004","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal Treatment of Acne and Hidradenitis Suppurativa in Adolescent Patients","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}